ImClone Investigational Site

Kalamazoo, Michigan 49048

0 studies enrolling now · 1 studies all time

What they study most

Colorectal Neoplasms, Metastases, Neoplasm

Studies at this site

• Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy — Completed